Overactive bladder: strategies to ensure treatment compliance and adherence

被引：17
|
作者：
Dhaliwal, Prabhpreet [1 ]
Wagg, Adrian [1 ]
机构：
[1] Univ Alberta, Dept Med, 1-108 Clin Sci Bldg,11350-83 Ave, Edmonton, AB T6G 2P4, Canada
来源：
CLINICAL INTERVENTIONS IN AGING | 2016年 / 11卷
关键词：
overactive bladder; persistence; adherence; URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; MEDICATION ADHERENCE; CONTINENCE SOCIETY; IMMEDIATE-RELEASE; EXTENDED-RELEASE; PERSISTENCE; INCONTINENCE; INTERVENTIONS; THERAPY;
D O I：
10.2147/CIA.S69636
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Overactive bladder is a common, debilitating condition for many patients who may benefit from pharmacological management of their condition. However, adherence to medication in this condition is markedly worse than other chronic medical conditions. This review explores what is known about persistence and the factors which influence medication adherence for overactive bladder, those factors that might be modifiable to improve adherence, and the measures the health care provider can take to optimize adherence to therapy and thereby improve treatment outcomes.
引用
收藏
页码：755 / 760
页数：6
相关论文
共 50 条
  • [21] Predictors of compliance with drug therapy in patients with overactive bladder
    Basra, R.
    Cortes, E.
    Basra, H.
    Khullar, V
    Kelleher, C.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 : S39 - S40
  • [22] Fesoterodine for the treatment of overactive bladder
    Belavic, Jennifer M.
    NURSE PRACTITIONER, 2009, 34 (08): : 14 - 15
  • [23] Medical Treatment of Overactive Bladder
    Sim, Hei Young
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2006, 49 (04): : 374 - 379
  • [24] Overactive bladder - pharmacological treatment
    Ricetto Sacomani, Carlos Alberto
    de Almeida, Fernando Goncalves
    Silvinato, Antonio
    Bernardo, Wanderley M.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (04): : 487 - 492
  • [25] Medical treatment of overactive bladder
    Rackley, R
    Wein, A
    Nelson, D
    MAYO CLINIC PROCEEDINGS, 2001, 76 (11) : 1179 - 1179
  • [26] Tolterodine for the treatment of overactive bladder
    Salvatore, Stefano
    Serati, Maurizio
    Bolis, Pierfrancesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (07) : 1249 - 1255
  • [27] Update on the treatment of overactive bladder
    Dmochowski, Roger R.
    Gomelsky, Alex
    CURRENT OPINION IN UROLOGY, 2011, 21 (04) : 286 - 290
  • [28] Solifenacin - Treatment of overactive bladder
    Chilman-Blair, K
    DRUGS OF TODAY, 2004, 40 (04) : 343 - 353
  • [29] Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature
    Sexton, C. C.
    Notte, S. M.
    Maroulis, C.
    Dmochowski, R. R.
    Cardozo, L.
    Subramanian, D.
    Coyne, K. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (05) : 567 - 585
  • [30] TREATMENT OF OVERACTIVE BLADDER IN WOMEN
    Aydin, Y.
    Aslan, E.
    OXIDATION COMMUNICATIONS, 2016, 39 (04): : 3168 - 3179
12345